HEALTH

iSatori to launch new weight-loss supplement

BY Alaric DeArment

GOLDEN, Colo. — Supplement maker iSatori has launched a new weight-loss supplement product, the company said.

BioGenetic Labs, a division of the company, announced Tuesday the pending launch of Belly-Off, a combination of conjugated linoleic acid, guarana, yerba mate and damiana designed to help users reduce belly fat. The company plans to start shipping the product this month and make it available at retailers nationwide in January 2013.

"Three newly published research studies revealed that while losing weight and reducing body fat, especially around the waist, can be very challenging, the process can benefit from daily supplementation of CLA combined with a new weight-loss energy blend we discovered called YGD," iSatori CEO Stephen Adele said. "In all three studies, subjects were shown to lose significantly more body fat than participants who were given a placebo."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

GSK to submit comments on FDA smoking-cessation products hearing

BY Alaric DeArment

PARSIPPANY, N.J. — The consumer products division of British drug maker GlaxoSmithKline wants its voice heard at a Food and Drug Administration hearing scheduled for next year on a section in a 2009 law to regulate tobacco products that deals with smoking-cessation products, the company said Monday.

GSK Consumer Healthcare said it would submit written comments to the FDA’s public docket in January 2013 concerning its positions on Sec. 918 of the Family Smoking Prevention and Tobacco Control Act of 2009, scheduled for April 2013. The section deals with products used to treat dependence on tobacco.

The purpose of the hearing is to advance the discussion of expanding the use of smoking cessation medicines, including nicotine-replacement therapy. The drug maker said it endorsed the FDA’s actions and "strongly" recommended that the agency adopt a comprehensive regulatory policy that allows smokers multiple approaches to quitting smoking, citing a study indicating that about 70% of the more than 45 million Americans who smoke want to quit.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Target launches new products, program for diabetics

BY Alaric DeArment

NEW YORK — Target has launched new products and a co-pay assistance program for customers with diabetes, the mass merchandise retailer said.

Target announced the release of new blood glucose meters and test strips. The retailer also offers products like alternative site lancets, alcohol prep pads and diabetic nutritional shakes.

The company also announced the launch of a $4 co-pay assistance program, as well as a free private-label blood glucose meter for customers who qualify for the program.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

M.JOHNSON says:
Jul-08-2013 05:09 pm

Although this article is old, I still felt it important to comment on how Target is making an effort to make a product line that is affordable for people to use to get the treatment they need. I always appreciate when large corporations give up some of their profits to help spread the word and raise awareness for healthy living. On my basketball apparel blog there is a page that focuses on how Nike has tried to help raise awareness for breast cancer. Anyway, thanks again for sharing and I hope more companies get on board with this movement.

J.HEWITT says:
Dec-18-2012 02:29 pm

Very smart of Target. This aligns their efforts with what Rite Aid is doing with their Diabetes Control project. Other retailers considering a similar strategy will be interested in the Diabetes-Pharmacy.com offering.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?